{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:35:59Z","timestamp":1781454959115,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T00:00:00Z","timestamp":1119916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmo"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00417-005-0005-8","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T21:51:31Z","timestamp":1119909091000},"page":"1147-1152","source":"Crossref","is-referenced-by-count":72,"title":["Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement"],"prefix":"10.1007","volume":"243","author":[{"given":"Masaru","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Hokama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaroh","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,6,28]]},"reference":[{"key":"5_CR1","first-page":"339","volume":"35","author":"C Barra","year":"1991","unstructured":"Barra C, Belfort Junior R, Abreu MT, Kim MK, Martins MC, Petrilli AM (1991) Behcet's disease in Brazil\u2014a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 35:339\u2013346","journal-title":"Jpn J Ophthalmol"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","volume":"70","author":"D Benezra","year":"1986","unstructured":"Benezra D, Cohen E (1986) Treatment and visual prognosis in Behcet's disease. Br J Ophthalmol 70:589\u2013592","journal-title":"Br J Ophthalmol"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00005792-197505000-00001","volume":"54","author":"T Chajek","year":"1975","unstructured":"Chajek T, Fainaru M (1975) Behcet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 54:179\u2013196","journal-title":"Medicine (Baltimore)"},{"key":"5_CR4","first-page":"318","volume":"30","author":"YM Chung","year":"1986","unstructured":"Chung YM, Liu JH, Tsi ST (1986) Behcet's disease in Taiwan\u2014a review of 53 cases. Jpn J Ophthalmol 30:318\u2013323","journal-title":"Jpn J Ophthalmol"},{"key":"5_CR5","first-page":"3233","volume":"42","author":"MD Smet De","year":"2001","unstructured":"De Smet MD, Bitar G, Mainigi S, Nussenblatt RB (2001) Human S-antigen determinant recognition in uveitis. Investig Ophthalmol Vis Sci 42:3233\u20133238","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0161-6420(97)30249-8","volume":"104","author":"H Demiroglu","year":"1997","unstructured":"Demiroglu H, Barista I, Dundar S (1997) Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey. Ophthalmology 104:701\u2013705","journal-title":"Ophthalmology"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjo.86.6.653","volume":"86","author":"H Er","year":"2002","unstructured":"Er H, Evereklioglu C, Cumurcu T, Turkoz Y, Ozerol E, Sahin K, Doganay S (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease. Br J Ophthalmol 86:653\u2013657","journal-title":"Br J Ophthalmol"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/0-306-48382-3_56","volume":"528","author":"NA Ermakova","year":"2003","unstructured":"Ermakova NA, Alekberova ZS, Prokaeva TB (2003) Autoimmunity to S-antigen and retinal vasculitis in patients with Behcet's disease. Adv Exp Med Biol 528:279\u2013281","journal-title":"Adv Exp Med Biol"},{"key":"5_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","volume":"11","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediat Inflamm 11:87\u201393","journal-title":"Mediat Inflamm"},{"key":"5_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00005792-195112000-00002","volume":"30","author":"R France","year":"1951","unstructured":"France R, Buchanan RN, Wilson MW, Sheldon MB Jr (1951) Relapsing iritis with recurrent ulcers of the mouth and genitalia (Behcet's syndrome); review: with report of additional case. Medicine (Baltimore) 30:335\u2013355","journal-title":"Medicine (Baltimore)"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/BF02030511","volume":"9","author":"M Hamza","year":"1990","unstructured":"Hamza M, Elleuch M, Slim A, Hamzaoui K, Ayed K (1990) Antibodies to Herpes simplex virus in patients with Behcet's disease. Clin Rheumatol 9:498\u2013500","journal-title":"Clin Rheumatol"},{"key":"5_CR12","first-page":"148","volume":"23","author":"H Kazokoglu","year":"1991","unstructured":"Kazokoglu H, Saatci O, Cuhadaroglu H, Eldem B (1991) Long-term effects of cyclophosphamide and colchicine treatment in Behcet's disease. Ann Ophthalmol 23:148\u2013151","journal-title":"Ann Ophthalmol"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","volume":"87","author":"I Kotter","year":"2003","unstructured":"Kotter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Gunaydin I, Grimbacher B, Blaschke S, Meyer-Riemann W, Peter HH, Stubiger N (2003) Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87:423\u2013431","journal-title":"Br J Ophthalmol"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/0-306-48382-3_34","volume":"528","author":"T Lehner","year":"2003","unstructured":"Lehner T, Stanford MR, Phipps PA, Sun JB, Xiao BG, Holmgren J, Shinnick T, Hasan A, Mizushima Y (2003) Immunopathogenesis and prevention of uveitis with the Behcet's disease-specific peptide linked to cholera toxin B. Adv Exp Med Biol 528:173\u2013180","journal-title":"Adv Exp Med Biol"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-1229(79)90058-8","volume":"13","author":"DK Martin","year":"1979","unstructured":"Martin DK, Nelms DC, Mackler BF, Peavy DL (1979) Lymphoproliferative responses induced by streptococcal antigens in recurrent aphthous stomatitis and Behcet's syndrome. Clin Immunol Immunopathol 13:146\u2013155","journal-title":"Clin Immunol Immunopathol"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","volume":"I","author":"K Masuda","year":"1989","unstructured":"Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet I:1093\u20131096","journal-title":"Lancet"},{"key":"5_CR17","first-page":"225","volume":"77","author":"S Mishima","year":"1979","unstructured":"Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K (1979) The eighth Frederick H. Verhoeff lecture presented by Saiichi Mishima, MD. Behcet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77:225\u2013279","journal-title":"Trans Am Ophthalmol Soc"},{"key":"5_CR18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(77)92945-2","volume":"II","author":"Y Mizushima","year":"1977","unstructured":"Mizushima Y, Matsumura N, Mori M, Shimizu T, Fukushima B, Mimura Y, Saito K, Sugiura S (1977) Colchicine in Behcet's disease. Lancet II:1037","journal-title":"Lancet"},{"key":"5_CR19","first-page":"66","volume":"28","author":"Y Mizushima","year":"1988","unstructured":"Mizushima Y (1988) Revised diagnostic criteria for Behcet's disease in 1987. Ryumachi 28:66\u201370","journal-title":"Ryumachi"},{"key":"5_CR20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9","volume":"32","author":"F Mor","year":"2002","unstructured":"Mor F, Weinberger A, Cohen IR (2002) Identification of alpha-tropomyosin as a target self-antigen in Behcet's syndrome. Eur J Immunol 32:356\u2013365","journal-title":"Eur J Immunol"},{"key":"5_CR21","first-page":"247","volume":"49","author":"Y Niwa","year":"1982","unstructured":"Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M (1982) Auto-oxidative damage in Behcet's disease\u2014endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49:247\u2013255","journal-title":"Clin Exp Immunol"},{"key":"5_CR22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780280611","volume":"28","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K (1985) Effectiveness of cyclosporin therapy for Behcet's disease. Arthritis Rheum 28:671\u2013679","journal-title":"Arthritis Rheum"},{"key":"5_CR23","first-page":"20","volume":"17","author":"P Pivetti Pezzi","year":"1985","unstructured":"Pivetti Pezzi P, Gasparri V, De Liso P, Catarinelli G (1985) Prognosis in Behcet's disease. Ann Ophthalmol 17:20\u201325","journal-title":"Ann Ophthalmol"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1568010023344535","volume":"1","author":"AM Reimold","year":"2002","unstructured":"Reimold AM (2002) TNF-alpha as therapeutic target: new drugs, more applications. Curr Drug Targets Inflamm Allergy 1:377\u2013392","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"5_CR25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0161-6420(95)31022-6","volume":"102","author":"M Sakamoto","year":"1995","unstructured":"Sakamoto M, Akazawa K, Nishioka Y, Sanui H, Inomata H, Nose Y (1995) Prognostic factors of vision in patients with Behcet disease. Ophthalmology 102:317\u2013321","journal-title":"Ophthalmology"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet's disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"5_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1468-3083.2003.t01-1-00574.x","volume":"17","author":"B Sancak","year":"2003","unstructured":"Sancak B, Onder M, Oztas MO, Bukan N, Gurer MA (2003) Nitric oxide levels in Behcet's disease. J Eur Acad Dermatol Venereol 17:7\u20139","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5_CR28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"PP Sfikakis","year":"2001","unstructured":"Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN (2001) Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet 358:295\u2013296","journal-title":"Lancet"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bjo.74.6.353","volume":"74","author":"HH Tessler","year":"1990","unstructured":"Tessler HH, Jennings T (1990) High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behcet's disease. Br J Ophthalmol 74:353\u2013357","journal-title":"Br J Ophthalmol"},{"key":"5_CR30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/ard.61.6.560","volume":"61","author":"G Triolo","year":"2002","unstructured":"Triolo G, Vadala M, Accardo-Palumbo A, Ferrante A, Ciccia F, Giardina E, Citarrella P, Lodato G, Licata G (2002) Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet's disease. Ann Rheum Dis 61:560\u2013561","journal-title":"Ann Rheum Dis"},{"key":"5_CR31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","volume":"8","author":"B Wechsler","year":"2000","unstructured":"Wechsler B, Bodaghi B, Huong DL, Fardeau C, Amoura Z, Cassoux N, Piette JC, LeHoang P (2000) Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet's disease. Ocul Immunol Inflamm 8:293\u2013301","journal-title":"Ocul Immunol Inflamm"},{"key":"5_CR32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-4362.1984.tb05658.x","volume":"23","author":"RC Wong","year":"1984","unstructured":"Wong RC, Ellis CN, Diaz LA (1984) Behcet's disease. Int J Dermatol 23:25\u201332","journal-title":"Int J Dermatol"},{"key":"5_CR33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","volume":"111","author":"A Yoshida","year":"2004","unstructured":"Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, Ando K, Hijikata K, Izawa Y, Hayashi K, Numaga J, Fujino Y, Masuda K, Araie M (2004) Comparison of patients with Behcet's disease in the 1980s and 1990s. Ophthalmology 111:810\u2013815","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-005-0005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-005-0005-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-005-0005-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:30:30Z","timestamp":1559071830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-005-0005-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,28]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1007\/s00417-005-0005-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,28]]}}}